Delivery Order SPE2DB20D3103-SPE2DB25FP6M6
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Taltz 80 mg/ml autoinjectors with a ceiling value of $4,197.10. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, reflecting a short fulfillment timeline for this pharmaceutical product. The contract utilizes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $14,482.79 delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL autoinjector medication. This is a firm fixed-price, non-set-aside contract with a completion date of July 28, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $19,605.32 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Taltz 80 mg/mL autoinjectors. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $4,052 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Taltz 80 MG/ML autoinjectors. The contract has a period of performance of one day, from July 13 to July 14, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the Defense Logistics Agency's requirement or programs supported by this pharmaceutical product. The award...
- This is a $12,799.25 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for Taltz 80 mg/mL autoinjector. The ultimate completion date for this order is August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure...
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- This is a $33,549.56 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Taltz 80 mg/mL autoinjector medication, a specialty pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
- This is a $14,331.27 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TALTZ 80 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of July 7, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
- This is a $51,809.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Taltz 80 mg/mL autoinjectors, a specialty medication used for various medical treatments. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a $4,052 delivery order to Amerisourcebergen Drug Corporation for Taltz 80 mg/ml autoinjectors. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between July 14-17, 2023. Amerisourcebergen will supply the requested pharmaceutical items to the Defense Logistics Agency under this short-term order to support the agency's medical logistics programs. No subcontractors or set aside designations...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6M6Delivery Order
The Defense Logistics Agency awarded a $4,133.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/mL auto-injector medication, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains extensive federal contract relationships primarily with the Defense Logistics Agency and its Medical Supply Chain. The company's portfolio includes a broad spectrum of pharmaceutical products and medical supplies supporting military and veteran healthcare systems worldwide. This specific delivery order for the immunosuppressant Taltz reflects the company's capability to supply specialty medications across multiple therapeutic domains through competitively awarded contracts under firm fixed-price arrangements, demonstrating its continued role as a key supplier within the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/25/25 |